Kinetics and Thermodynamics of Amyloid Assembly Using a High‐Performance Liquid Chromatography–Based Sedimentation Assay

Andreu, 1986, The measurement of cooperative protein self‐assembly by turbidity and other techniques, Methods Enzymol., 130, 47, 10.1016/0076-6879(86)30007-7 Berthelier, 2001, A microtiter plate assay for polyglutamine aggregate extension, Anal. Biochem., 295, 227, 10.1006/abio.2001.5217 Bhattacharyya, 2005, Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction, Proc. Natl. Acad. Sci. USA, 102, 15400, 10.1073/pnas.0501651102 Bhattacharyya, 2006, Oligoproline effects on polyglutamine conformation and aggregation, J. Mol. Biol., 355, 524, 10.1016/j.jmb.2005.10.053 Bucciantini, 2002, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature, 416, 507, 10.1038/416507a Cannon, 2004, Kinetic analysis of Aβ fibril elongation, Anal. Biochem., 328, 67, 10.1016/j.ab.2004.01.014 Chen, 2002, Amyloid‐like features of polyglutamine aggregates and their assembly kinetics, Biochemistry, 41, 7391, 10.1021/bi011772q Chen, 2001, Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity, J. Mol. Biol., 311, 173, 10.1006/jmbi.2001.4850 Chen, 2002, Huntington's disease age‐of‐onset linked to polyglutamine aggregation nucleation, Proc. Natl. Acad. Sci. USA, 99, 11884, 10.1073/pnas.182276099 Chen, 2001, Solubilization and disaggregation of polyglutamine peptides, Protein Sci., 10, 887, 10.1110/ps.42301 Collins, 2004, Mechanism of prion propagation: Efficient amyloid growth in the absence of oligomeric intermediates, PLoS, 2, 1582, 10.1371/journal.pbio.0020321 Colon, 1999, Analysis of protein structure by solution optical spectroscopy, Methods Enzymol., 309, 605, 10.1016/S0076-6879(99)09041-2 DePace, 2002, Origins and kinetic consequences of diversity in Sup35 yeast prion fibers, Nat. Struct. Biol., 9, 389 Diamandis, 1988, Immunoassays with time‐resolved fluorescence spectroscopy: Principles and applications, Clin. Biochem., 21, 139, 10.1016/0009-9120(88)90001-X Esler, 1997, A beta deposition inhibitor screen using synthetic amyloid, Nat. Biotechnol., 15, 258, 10.1038/nbt0397-258 Esler, 2000, Alzheimer's disease amyloid propagation by a template‐dependent dock‐lock mechanism, Biochemistry, 39, 6288, 10.1021/bi992933h Evans, 1995, Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92, 763, 10.1073/pnas.92.3.763 Falk, 1997, The systemic amyloidoses [see comments], N. Engl. J. Med., 337, 898, 10.1056/NEJM199709253371306 Ferrone, 1999, Analysis of protein aggregation kinetics, Methods Enzymol., 309, 256, 10.1016/S0076-6879(99)09019-9 Franks, 1993, Storage stabilization of proteins, 489 Goldsbury, 2005, Multiple assembly pathways underlie amyloid‐beta fibril polymorphisms, J. Mol. Biol., 352, 282, 10.1016/j.jmb.2005.07.029 Gosal, 2005, Competing pathways determine fibril morphology in the self‐assembly of beta2‐microglobulin into amyloid, J. Mol. Biol., 351, 850, 10.1016/j.jmb.2005.06.040 Harper, 1997, Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid‐beta protein, Chem. Biol., 4, 951, 10.1016/S1074-5521(97)90303-3 Heller, 1996, Solid‐state NMR studies of the prion protein H1 fragment, Protein Sci., 5, 1655, 10.1002/pro.5560050819 Hilbich, 1992, Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease bA4 peptides, J. Mol. Biol., 228, 460, 10.1016/0022-2836(92)90835-8 Howlett, 1995, Aggregation state and neurotoxic properties of Alzheimer beta‐amyloid peptide, Neurodegeneration, 4, 23, 10.1006/neur.1995.0003 Hurle, 1994, A role for destabilizing amino acid replacements in light chain amyloidosis, Proc. Natl. Acad. Sci. USA, 91, 5446, 10.1073/pnas.91.12.5446 Ignatova, 2005, Aggregation of a slow‐folding mutant of a beta‐clam protein proceeds through a monomeric nucleus, Biochemistry, 44, 7266, 10.1021/bi047404e Jarrett, 1992, Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB, Biochemistry, 31, 12345, 10.1021/bi00164a008 Jones, 2005, Fibril conformation as the basis of species‐ and strain‐dependent seeding specificity of Mammalian prion amyloids, Cell, 121, 63, 10.1016/j.cell.2005.01.034 Klunk, 1999, Quantifying amyloid by Congo red spectral shift assay, Methods Enzymol., 309, 285, 10.1016/S0076-6879(99)09021-7 Kopito, 2000, Aggresomes, inclusion bodies and protein aggregation, Trends Cell. Biol., 10, 524, 10.1016/S0962-8924(00)01852-3 LeVine, 1999, Quantification of β‐sheet amyloid fibril structures with thioflavin T, Methods Enzymol., 309, 274, 10.1016/S0076-6879(99)09020-5 Lomakin, 1999, Monitoring protein assembly using quasielastic light scattering spectroscopy, Methods Enzymol., 309, 429, 10.1016/S0076-6879(99)09029-1 Martin, 1999, Molecular basis of the neurodegenerative disorders, N. Engl. J. Med., 340, 1970, 10.1056/NEJM199906243402507 McCutchen, 1993, Transthyretin mutation Leu‐55‐Pro significantly alters tetramer stability and increases amyloidogenicity, Biochemistry, 32, 12119, 10.1021/bi00096a024 Meijer, 2004, Regulation and role of autophagy in mammalian cells, Int. J. Biochem. Cell. Biol., 36, 2445, 10.1016/j.biocel.2004.02.002 Merkel, 1999, Sidechain interactions in parallel beta sheets: The energetics of cross‐strand pairings, Structure Fold Des., 7, 1333, 10.1016/S0969-2126(00)80023-4 Merlini, 2003, Molecular mechanisms of amyloidosis, N. Engl. J. Med., 349, 583, 10.1056/NEJMra023144 Mitraki, 1989, Protein folding intermediates and inclusion body formation, Biotech., 7, 690, 10.1038/nbt0789-690 Mulkerrin, 1989, pH dependence of the reversible and irreversible thermal denaturation of γ interferons, Biochem., 28, 6556, 10.1021/bi00442a005 Neurath, 1944, The chemistry of protein denaturation, Chem. Rev., 34, 157, 10.1021/cr60108a003 Nichols, 2005, Amyloid‐beta protofibrils differ from amyloid‐beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology, J. Biol. Chem., 280, 2471, 10.1074/jbc.M410553200 Nilsson, 2004, Techniques to study amyloid fibril formation in vitro, Methods, 34, 151, 10.1016/j.ymeth.2004.03.012 O'Nuallain, 2005, Thermodynamics of abeta(1‐40) amyloid fibril elongation, Biochemistry, 44, 12709, 10.1021/bi050927h O'Nuallain, 2004, Seeding specificity in amyloid growth induced by heterologous fibrils, J. Biol. Chem., 279, 17490, 10.1074/jbc.M311300200 Petkova, 2005, Self‐propagating, molecular‐level polymorphism in Alzheimer's β‐amyloid fibrils, Science, 307, 262, 10.1126/science.1105850 Serio, 2000, Nucleated conformational conversion and the replication of conformational information by a prion determinant, Science, 289, 1317, 10.1126/science.289.5483.1317 Sharma, 2005, Polyglutamine homopolymers having 8–45 residues form slablike beta‐crystallite assemblies, Proteins, 61, 398, 10.1002/prot.20602 Shivaprasad, 2004, An intersheet packing interaction in Aβ fibrils mapped by disulfide crosslinking, Biochemistry, 43, 15310, 10.1021/bi048019s Shivaprasad, 2006, Scanning cysteine mutagenesis analysis of Aβ(1‐40) amyloid fibrils, J. Biol. Chem., 281, 993, 10.1074/jbc.M505091200 Stefani, 2003, Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution, J. Mol. Med., 81, 678, 10.1007/s00109-003-0464-5 Tanaka, 2004, Conformational variations in an infectious protein determine prion strain differences, Nature, 428, 323, 10.1038/nature02392 Thakur, 2002, Mutational analysis of the structural organization of polyglutamine aggregates, Proc. Natl. Acad. Sci. USA, 99, 17014, 10.1073/pnas.252523899 Wetzel, 1994, Mutations and off‐pathway aggregation, Trends Biotechnol., 12, 193, 10.1016/0167-7799(94)90082-5 Wetzel, 2005, Protein folding and aggregation in the expanded polyglutamine repeat diseases, 1170 Williams, 2004, Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis, J. Mol. Biol., 335, 833, 10.1016/j.jmb.2003.11.008 Williams, 2005, Structural properties of Aβ protofibrils stabilized by a small molecule, Proc. Natl. Acad. Sci. USA, 102, 7115, 10.1073/pnas.0408582102 Williams, 2006, Alanine scanning mutagenesis of Aβ(1‐40) amyloid fibril stability, J. Mol. Biol., 10.1016/j.jmb.2006.01.041 Wood, 1996, Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's peptide Ab, J. Mol. Biol., 256, 870, 10.1006/jmbi.1996.0133 Yamaguchi, 2005, Seeding‐dependent propagation and maturation of amyloid fibril conformation, J. Mol. Biol., 352, 952, 10.1016/j.jmb.2005.07.061 Yang, 2002, Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells, Hum. Mol. Genet., 11, 2905, 10.1093/hmg/11.23.2905 Zagorski, 1999, Methodological and chemical factors affecting amyloid‐β amyloidogenicity, Methods Enzymol., 309, 189, 10.1016/S0076-6879(99)09015-1 Zhang, 2000, The Alzheimer's peptide a beta adopts a collapsed coil structure in water, J. Struct. Biol., 130, 130, 10.1006/jsbi.2000.4288